The FLT3 ITD D835Y Mutation Detection Test is a specialized diagnostic procedure designed to identify specific mutations within the FLT3 gene, namely the internal tandem duplication (ITD) and the D835Y point mutation. These mutations are significant because they are often found in patients with acute myeloid leukemia (AML), and their presence can influence treatment choices and prognostic outlooks. The test utilizes advanced molecular techniques to analyze the FLT3 gene from a patient's blood or bone marrow sample, ensuring accurate detection of these mutations.
The cost of the FLT3 ITD D835Y Mutation Detection Test is set at 1200 AED. It is performed at DNA Labs UAE, a facility renowned for its state-of-the-art genetic testing services. This lab employs cutting-edge technology and highly qualified professionals to provide reliable and precise test results, aiding in the effective management and treatment planning for patients with AML.
The "Frozen-2 Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to provide comprehensive insights into specific health markers or conditions. Priced at 1200 AED, this test utilizes advanced genetic analysis techniques to examine DNA samples, offering detailed results that can aid in understanding genetic predispositions, potential health risks, or the effectiveness of certain treatments. DNA Labs UAE is equipped with state-of-the-art facilities and staffed by expert professionals to ensure accurate and reliable test outcomes. Whether for preventive health measures, diagnostic purposes, or personalized medicine, the "Frozen-2 Test" represents a significant advancement in medical diagnostics, offering individuals a deeper understanding of their health and well-being.
The HbE Hemoglobin E Mutation Screening Prenatal Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying the presence of the Hemoglobin E (HbE) mutation in unborn babies. This mutation leads to a variant form of hemoglobin, which can result in various health issues ranging from mild anemia to severe beta-thalassemia when combined with other hemoglobin mutations. The test is particularly crucial for expectant parents with a family history of hemoglobin disorders or those belonging to regions where these mutations are prevalent.
Conducted through a sample of amniotic fluid or chorionic villi obtained via amniocentesis or chorionic villus sampling (CVS), this prenatal screening plays a vital role in early detection, allowing for better preparedness and management of potential health conditions associated with the HbE mutation. Priced at 1200 AED, the test is a valuable investment for parents looking to ensure the well-being of their child, offering peace of mind and the possibility to consult with healthcare professionals for further steps and considerations based on the screening outcome.
The Hemoglobin D Punjab (HbD) Mutation Study Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to detect the presence of the HbD mutation, a variant form of hemoglobin. Hemoglobin is a protein in red blood cells responsible for carrying oxygen throughout the body. The HbD Punjab variant, also known as HbD Los Angeles or simply HbD, is one of the many hemoglobin variants that can affect the structure and function of hemoglobin. This particular variant is most commonly found in people of Punjabi descent but can occur in other populations as well.
The test is crucial for identifying individuals who carry the HbD mutation, as it can lead to conditions like hemoglobin D disease or, when combined with other hemoglobin mutations such as sickle cell trait, result in more severe disorders like sickle cell disease. Early detection through the Hemoglobin D Punjab HbD Mutation Study Test allows for appropriate genetic counseling and management strategies to mitigate health risks associated with the mutation.
Conducted at the state-of-the-art facilities of DNA Labs UAE, the test involves a simple blood draw from the patient. The sample is then analyzed using advanced genetic testing techniques to identify the presence of the HbD mutation. The cost of the test is 1200 AED, reflecting the sophisticated technology and expertise required to accurately detect and analyze the mutation.
Patients or individuals who suspect they might carry the mutation, or those with a family history of hemoglobin variants, are encouraged to consider this test. Early diagnosis can be essential in managing potential health issues and making informed decisions about family planning.
The Hepatitis-B Virus (HBV) Quantitative PCR Test is a sophisticated diagnostic procedure aimed at detecting and quantifying the presence of HBV DNA in a patient's blood. This molecular testing method employs Polymerase Chain Reaction (PCR) technology, which amplifies small segments of the virus's DNA to measurable levels. It is a critical tool for healthcare providers in assessing viral load, guiding treatment decisions, and monitoring the effectiveness of antiviral therapy in patients with chronic HBV infection.
Performed at DNA Labs UAE, a reputable facility known for its advanced diagnostic services, the HBV Quantitative PCR Test offers a highly sensitive and specific assessment of the HBV viral load. The test cost is set at 1200 AED, reflecting the intricate technology and expertise required to conduct this sophisticated analysis. By providing precise quantification of the HBV DNA, this test plays a pivotal role in the management of hepatitis B, helping to prevent liver damage and reduce the risk of liver cancer in infected individuals.
The Hereditary Persistence of Fetal Hemoglobin (HPFH) test is a specialized genetic analysis designed to detect mutations associated with the continued production of fetal hemoglobin (HbF) into adulthood. Fetal hemoglobin is a type of hemoglobin that is normally present in fetuses and infants, providing efficient oxygen transport from the mother's bloodstream. In individuals with HPFH, this form of hemoglobin persists at elevated levels beyond infancy, which can have implications for certain blood disorders, including sickle cell disease and beta-thalassemia.
The test involves collecting a blood sample from the individual, which is then analyzed for specific genetic markers indicative of HPFH. These markers include mutations in the HBG1 and HBG2 genes, among others, that are responsible for the regulation of hemoglobin production. Identifying the presence of these mutations can aid in the diagnosis of HPFH, inform treatment strategies for related hemoglobinopathies, and provide valuable information for genetic counseling.
In the United Arab Emirates, the HPFH test is available at DNA Labs UAE, a leading facility in genetic diagnostics. The cost of the test is 1200 AED, making it accessible for individuals seeking to understand their genetic predisposition to persistent fetal hemoglobin production and its implications for their health. DNA Labs UAE employs state-of-the-art technology and expertise to ensure accurate and reliable test results, offering a crucial resource for patients and healthcare providers in managing and understanding hemoglobin-related disorders.
The Human Papilloma Virus (HPV) Genotype Test is a sophisticated diagnostic procedure aimed at detecting the presence of HPV, a virus linked to several types of cancers, including cervical, anal, and oropharyngeal cancers. This test specifically identifies the types or genotypes of HPV present in the body, which is crucial for assessing the risk of developing these cancers. Given the variety of HPV strains, some of which are considered high-risk for leading to cancer, genotyping plays a critical role in preventive health measures and in guiding appropriate clinical interventions.
DNA Labs UAE offers this vital test for a cost of 1200 AED. The test is performed in a state-of-the-art laboratory setting by skilled professionals who specialize in molecular diagnostic techniques. By utilizing advanced technology, DNA Labs UAE ensures accurate, reliable, and timely results, which are essential for effective management and treatment planning. This test is recommended for individuals who are at risk of HPV infections or for those seeking comprehensive health assessments as part of preventive healthcare measures.
The JAK2 Gene V617F Quantitative Test is a specialized diagnostic procedure designed to detect the presence of the V617F mutation in the Janus kinase 2 (JAK2) gene. This mutation is commonly associated with a group of blood cancers known as myeloproliferative neoplasms (MPNs), including polycythemia vera, essential thrombocythemia, and primary myelofibrosis. The test plays a crucial role in the diagnosis and management of these conditions, helping to guide treatment decisions and monitor disease progression.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves a blood sample from the patient. Utilizing advanced molecular techniques, the laboratory professionals accurately quantify the presence of the JAK2 V617F mutation, providing valuable insights into the patient's condition. The cost of the test is 1200 AED, reflecting the specialized nature of the analysis and the expertise required to interpret the results.
Choosing DNA Labs UAE for the JAK2 Gene V617F Quantitative Test ensures patients receive high-quality diagnostic services, benefiting from the lab's commitment to accuracy, confidentiality, and support throughout the testing process.
The "Large Biopsy 3 Test" is a specialized diagnostic procedure offered at DNA Labs UAE, designed to analyze a substantial sample of tissue from the body to detect the presence of diseases, including various types of cancers. This comprehensive test is crucial for patients undergoing diagnosis for suspicious growths or abnormalities identified in earlier screenings. By examining a large biopsy, pathologists can provide a more accurate diagnosis, assess the stage of a disease, and recommend an appropriate treatment plan.
Performed in the state-of-the-art facilities of DNA Labs UAE, this test employs advanced molecular and histopathological techniques to analyze the biopsy sample. The process involves careful preparation of the tissue, followed by detailed microscopic examination and possibly molecular testing to identify specific genetic markers or abnormalities. This thorough approach ensures high diagnostic accuracy and is pivotal in personalized medicine, allowing for treatments tailored to the genetic makeup of a patient's condition.
The cost of the "Large Biopsy 3 Test" at DNA Labs UAE is set at 1200 AED. While the price may seem significant, the value of obtaining a precise diagnosis cannot be overstated, as it directly influences the effectiveness of subsequent medical interventions. Patients choosing DNA Labs UAE for this test can expect not only reliable results but also a supportive and confidential service throughout their diagnostic journey.
The Methylenetetrahydrofolate Reductase (MTHFR) - 2 Variants C677T A1298C Test is a specialized genetic examination offered by DNA Labs UAE, designed to identify mutations in the MTHFR gene. Specifically, this test focuses on two common variants, C677T and A1298C, which have been associated with a range of health issues, including increased risk of cardiovascular diseases, stroke, and certain types of thrombophilia. The MTHFR enzyme plays a crucial role in processing amino acids, the building blocks of proteins, and is vital for a process known as methylation. Alterations in this enzyme's function due to genetic mutations can lead to elevated levels of homocysteine in the blood, a risk factor for various health conditions.
DNA Labs UAE offers this test at a cost of 1200 AED. The process involves a simple blood sample from which DNA is extracted and analyzed for the presence of the C677T and A1298C mutations. This test is essential for individuals with a family history of related health issues or those experiencing symptoms that could be linked to MTHFR mutations. Understanding one's genetic makeup in relation to the MTHFR gene can help in making informed decisions regarding lifestyle, dietary adjustments, and medical interventions to mitigate potential health risks.
